Photo from archive.org
Implementing the watch-and-wait (WW) approach for rectal cancer patients who respond well to neoadjuvant therapy is oncologically safe and can preserve the patient’s quality of life that often is sacrificed… Click to show full abstract
Implementing the watch-and-wait (WW) approach for rectal cancer patients who respond well to neoadjuvant therapy is oncologically safe and can preserve the patient’s quality of life that often is sacrificed by total mesorectal excision (TME). However, the data of WW on patient survival are limited to retrospective studies because a prospective randomized trial comparing TME with WW is not feasible.
Keywords:
aso author;
cancer patients;
watch wait;
rectal cancer
Journal Title: Annals of Surgical Oncology
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Annals of Surgical Oncology
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!